|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ultrasound assessment of flow-mediated dilation显示文摘 | Harris RA Nishiyama SK Wray DW | 2010 | Hypertension2010，55，： | 1 |
| 2 | Sox proteins in melanocyte development and melanoma 显示文摘 | Harris ML Baxter LL Loftus SK | 2010 | Pigment Cell Melanoma Res2010，23，4： | 1 |
| 3 | Reversal of P-glycoprotien mediated multidrug resistance by pure antioestrogens and novel tamoxifen derivatives显示文摘 | Kirk J Syed SK Harris AL | 1994 | Biochem Pharmacol1994，48，： | 1 |
| 4 | Adolescents'preference for substance abuse screening in primary care practice 显示文摘 | Knight JR Harris SK Sherritt L | 2007 | Subst Abus2007，28，4： | 1 |
| 5 | Prevalence of positive substance abuse screen results among adolescent primary care patients 显示文摘 | Knight JR Harris SK Sherritt L | 2007 | Arch Pediatr Adolesc Med2007，161，11： | 1 |
| 6 | Phenylarsine oxide blocks interleukin - 1β - induced activation of the nuclear transcription factor NF- kB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells 显示文摘 | Estrov Z Mamla Sk Harris D | 1999 | Blood1999，94，8： | 1 |
| 7 | Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins显示文摘 | Harry JL Sebastian L | 2003 | J Proteome Res2003，2，3： | 1 |
| 8 | Broad vaccine cov- erage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease显示文摘 | Jiang HQ Hoiseth SK Harris SL etal | 2010 | Vaccine2010，28，： | 1 |
| 9 | Sox proteins in melanocyte development and melanoma显示文摘 | Harris ML Baxter LL Loftus SK | | 0，，04： | 1 |
| 10 | The Withdrawal As- sessment Tool-1 (WAT-1):an assessment instrument for moni- toting opioid and benzodiazepine withdrawal symptoms in pe- diatric patients显示文摘 | Franck LS Harris SK Soetenga DJ | 2008 | Pediatr Crit Care Med2008，9，6： | 1 |
| 11 | Clinical laboratory: enzyme immunoassay for the rapid clinical identification of snake venom显示文摘 | Coulter AR Harris RD Sutherland SK | 1980 | Med J Aust1980，19，9： | 1 |
| 12 | Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety 显示文摘 | Kelley SK Harris LA Xie D | 2001 | J Pharmacol Exp Ther2001，299，： | 1 |
| 13 | Preclinical studies to predict the disposition of Apo2L/ tumor necrosis factor-related apoptosis-inducing ligand in humans:characterization of in vivo efficacy,pharmacokinetics,and safety显示文摘 | KELLEY SK HARRIS LA XIE D | 2001 | J Pharmacol Exp Ther2001，299，1： | 1 |
| 14 | Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety显示文摘 | Kelley SK Harris LA Xie D | 2001 | J Pharmacol Exp Ther2001，299，1： | 1 |
| 15 | Clinical laboratory:enzyme immunoassay for the rapid clinical identification of snake venom 显示文摘 | Coulter AR Harris RD Sutherland SK | 1980 | Med J Aust1980，1，9： | 1 |
| 16 | The use of Lean Thinking techniques in implementing the Department of Health, UK, 18-week waiting time directive for cochlear implantation显示文摘 | Kullar P Harris F Lloyd SK | 2010 | Cochlear Implants Interna- tional2010，11，3： | 1 |
| 17 | Neurocogni-tive allied phenotypes for schizophrenia and bipolar disor-der显示文摘 | Hill SK Harris MSH Herbener ES | 2008 | Schizophr Bull2008，34，4： | 1 |
| 18 | RNA edifng enzyme APOBEC1 and some of its homologs can act as DNA mutators 显示文摘 | Petersen-Mahrt SK Neuberger MS | 2002 | Mol Cell2002，10，5： | 1 |
| 19 | RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators显示文摘 | Harris RS Petersen-Mahrt SK Neuberger MS | 2002 | Mol Cell2002，10，： | 1 |
| 20 | Ultrasound assessment of flow-mediated dilation显示文摘 | HARRIS RA NISHIYAMA SK WRAY DW | 2010 | Hypertension2010，55，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员